US Patent

US8741920 — Process for the manufacture of pharmaceutically active compounds

Composition of Matter · Assigned to Hoffmann La Roche Inc · Expires 2030-07-27 · 4y remaining

Vulnerability score 15/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects a process for manufacturing the compound of formula (1) and the compound of formula (B).

USPTO Abstract

The present invention relates to a composition comprising the compound of formula (1), and the compound of formula (B),

Drugs covered by this patent

Patent Metadata

Patent number
US8741920
Jurisdiction
US
Classification
Composition of Matter
Expires
2030-07-27
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Hoffmann La Roche Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.